January 5, 2022

AstraZeneca completes transfer of its global rights to Eklira and Duaklir to Covis Pharma

AstraZeneca plc (LON:AZN) has completed the transfer of its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/formoterol) to Covis Pharma Group (Covis..

BlackRock Latin American Investment Trust declares fourth quarterly interim dividend of 6.21 cents

BlackRock Latin American Investment Trust plc (LON:BRLA) has announced the fourth quarterly interim dividend in respect of the financial year to 31 December 2021 of 6.21 cents per ordinary share...

Time Finance notice of interim results

Time Finance plc (LON:TIME), the AIM listed independent specialist finance provider, as previously announced, confirms that it plans to announce unaudited interim results for the six-month period ended 30 November..

Search

Funds

January 5, 2022

Search

Funds

January 5, 2022

FTSE 100

Funds